Literature DB >> 10548507

Basic fibroblast growth factor induces osteoclast formation by reciprocally regulating the production of osteoclast differentiation factor and osteoclastogenesis inhibitory factor in mouse osteoblastic cells.

N Nakagawa1, H Yasuda, K Yano, S i Mochizuki, N Kobayashi, H Fujimoto, N Shima, T Morinaga, D Chikazu, H Kawaguchi, K Higashio.   

Abstract

Basic fibroblast growth factor (bFGF) induced osteoclast formation in co-cultures of mouse spleen cells and osteoblasts. Osteoclastogenesis inhibitory factor (OCIF) and a selective cyclooxygenase-2 (COX-2) inhibitor, NS-398, abolished bFGF-induced osteoclast formation. bFGF did not affect spleen cells, but it did affect osteoblasts, to stimulate osteoclast formation. Northern blot analysis revealed that bFGF up-regulated the expression of osteoclast differentiation factor (ODF) and COX-2 and down-regulated the expression of OCIF in primary osteoblastic cells. NS-398 abolished the increase of ODF mRNA, but it had no effect on the decrease of OCIF mRNA. NS-398 suppressed the binding of (125)I-labeled OCIF to osteoblastic cells treated with bFGF. Enzyme-linked immunosorbent assay showed that bFGF inhibited OCIF production by osteoblastic cells, and the inhibition was not affected by NS-398. We conclude that bFGF induces osteoclast formation by stimulating ODF production through COX-2-mediated prostaglandin synthesis and by suppressing OCIF production through a mechanism independent of prostaglandin synthesis. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10548507     DOI: 10.1006/bbrc.1999.1601

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

Review 1.  Role of the RANK/RANKL/OPG and Wnt/β-Catenin Systems in CKD Bone and Cardiovascular Disorders.

Authors:  Natalia Carrillo-López; Laura Martínez-Arias; Jorge B Cannata-Andía; Manuel Naves-Díaz; Sara Panizo; Sara Fernández-Villabrille; María Piedad Ruiz-Torres; Adriana Dusso
Journal:  Calcif Tissue Int       Date:  2021-02-13       Impact factor: 4.333

2.  Exported 18-kDa isoform of fibroblast growth factor-2 is a critical determinant of bone mass in mice.

Authors:  Liping Xiao; Peng Liu; Xiaofeng Li; Thomas Doetschman; J Douglas Coffin; Hicham Drissi; Marja M Hurley
Journal:  J Biol Chem       Date:  2008-12-04       Impact factor: 5.157

3.  DACH1 negatively regulates the human RANK ligand gene expression in stromal/preosteoblast cells.

Authors:  Kumaran Sundaram; Santhosh K Mani; Kazuyuki Kitatani; Kongming Wu; Richard G Pestell; Sakamuri V Reddy
Journal:  J Cell Biochem       Date:  2008-04-15       Impact factor: 4.429

4.  Pulsed electromagnetic field stimulates osteoprotegerin and reduces RANKL expression in ovariectomized rats.

Authors:  Jun Zhou; Shiju Chen; Hua Guo; Lu Xia; Huifang Liu; Yuxi Qin; Chengqi He
Journal:  Rheumatol Int       Date:  2012-09-05       Impact factor: 2.631

5.  FGF-2 stimulation of RANK ligand expression in Paget's disease of bone.

Authors:  Kumaran Sundaram; Joseph Senn; Sambandam Yuvaraj; D Sudhaker Rao; Sakamuri V Reddy
Journal:  Mol Endocrinol       Date:  2009-06-25

Review 6.  Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease.

Authors:  Ann E Kearns; Sundeep Khosla; Paul J Kostenuik
Journal:  Endocr Rev       Date:  2007-12-05       Impact factor: 19.871

7.  Down-regulation by resveratrol of basic fibroblast growth factor-stimulated osteoprotegerin synthesis through suppression of Akt in osteoblasts.

Authors:  Gen Kuroyanagi; Takanobu Otsuka; Naohiro Yamamoto; Rie Matsushima-Nishiwaki; Akira Nakakami; Jun Mizutani; Osamu Kozawa; Haruhiko Tokuda
Journal:  Int J Mol Sci       Date:  2014-10-06       Impact factor: 5.923

8.  Dual Therapeutic Action of a Neutralizing Anti-FGF2 Aptamer in Bone Disease and Bone Cancer Pain.

Authors:  Ling Jin; Yosuke Nonaka; Shin Miyakawa; Masatoshi Fujiwara; Yoshikazu Nakamura
Journal:  Mol Ther       Date:  2016-08-10       Impact factor: 11.454

9.  Prevention of tooth extraction-triggered bisphosphonate-related osteonecrosis of the jaws with basic fibroblast growth factor: An experimental study in rats.

Authors:  Mitsuhiko Imada; Takahiro Yagyuu; Yoshihiro Ueyama; Masahiko Maeda; Kazuhiko Yamamoto; Satoshi Kurokawa; Jun-Ichiro Jo; Yasuhiko Tabata; Yasuhito Tanaka; Tadaaki Kirita
Journal:  PLoS One       Date:  2019-02-08       Impact factor: 3.240

Review 10.  Multiple Therapeutic Applications of RBM-007, an Anti-FGF2 Aptamer.

Authors:  Yoshikazu Nakamura
Journal:  Cells       Date:  2021-06-28       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.